Sledovať
Alexander Vaiserman
Alexander Vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Overená e-mailová adresa na: geront.kiev.ua
Názov
Citované v
Citované v
Rok
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17, 1-6, 2017
9822017
Gut microbiota: A player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
4522017
Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives
A Vaiserman, D Krasnienkov
Frontiers in genetics 11, 630186, 2021
3142021
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
2292018
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
2022015
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1772015
Nanodelivery of natural antioxidants: an anti-aging perspective
A Vaiserman, A Koliada, A Zayachkivska, O Lushchak
Frontiers in bioengineering and biotechnology 7, 447, 2020
1662020
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
1602014
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population
A Vaiserman, M Romanenko, L Piven, V Moseiko, O Lushchak, ...
BMC microbiology 20, 1-8, 2020
1552020
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1502010
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
1382016
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
1182011
Metformin as a geroprotector: experimental and clinical evidence
V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak
Biogerontology 20, 33-48, 2019
1132019
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
1092015
Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge?
AM Vaiserman, AK Koliada
Human genomics 11, 1-15, 2017
1072017
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
1042017
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
1022014
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7, 1-11, 2015
962015
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50, 32-35, 2007
872007
Insulin-Like Peptides Regulate Feeding Preference and Metabolism in Drosophila
UV Semaniuk, DV Gospodaryov, KM Feden'Ko, IS Yurkevych, ...
Frontiers in physiology 9, 1083, 2018
832018
Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.
Články 1–20